Enrica Borgogno

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?

G. di Perri, A. Calcagno, I. Motta, 2021, International journal of antimicrobial agents.

Risk Factors for Mortality in COVID-19 Hospitalized Patients in Piedmont, Italy: Results from the Multicenter, Regional, CORACLE Registry

T. Lupia, F. D. De Rosa, G. di Perri, 2021, Journal of clinical medicine.

Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV.

C. Atzori, G. di Perri, A. Calcagno, 2020, AIDS.